Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xinyu Ding

Showing results (71-80 of 82) with videos related to

Pageof 9
Sort By:
European Journal of Medicinal Chemistry|July 3, 2021
Discovery of novel BCR-ABL PROTACs based on the cereblon E3 ligase design, synthesis, and biological evaluationHaixia Liu, Xinyu Ding, Linyi Liu, et al.
Cancer Research|February 25, 2010
Suppression of cyclin D1 by hypoxia-inducible factor-1 via direct mechanism inhibits the proliferation and 5-fluorouracil-induced apoptosis of A549 cellsWen Wen, Jin Ding, Wen Sun, et al.
Journal of Medicinal Chemistry|September 21, 2019
Discovery of SIAIS178 as an Effective BCR-ABL Degrader by Recruiting Von Hippel-Lindau (VHL) E3 Ubiquitin LigaseQuanju Zhao, Chaowei Ren, Linyi Liu, et al.
Scientific Data|May 25, 2024
Head model dataset for mixed reality navigation in neurosurgical interventions for intracranial lesionsZiyu Qi, Haitao Jin, Xinghua Xu, et al.
Communications Biology|November 22, 2025
Genomic and spatial heterogeneity of Brucella melitensis underscores latent brucellosis risks in non-endemic zones in Southwest ChinaFuping Yang, Xiyang Li, Binbin Yu, et al.
Iscience|August 4, 2023
Targeting Bcl-xL is a potential therapeutic strategy for extranodal NK/T cell lymphomaChuanxu Liu, Xinyu Ding, Gaoyang Li, et al.
European Journal of Medicinal Chemistry|October 28, 2022
Discovery and characterization of novel potent BCR-ABL degraders by conjugating allosteric inhibitorHaixia Liu, Qianglong Mi, Xinyu Ding, et al.
Biochemical and Biophysical Research Communications|April 16, 2023
Mechanism of an RBM-targeted rabbit monoclonal antibody 9H1 neutralizing SARS-CoV-2Xiaoyu Chu, Xinyu Ding, Yixuan Yang, et al.
Cell Reports. Medicine|August 26, 2025
An age-related decrease in leptin contributes to CD8<sup>+</sup> T cell aging in the tumor microenvironmentFeixiang Wang, Rujuan Bao, Shuiyu Xu, et al.
Nature Communications|April 2, 2022
Single-cell and spatial analysis reveal interaction of FAP<sup>+</sup> fibroblasts and SPP1<sup>+</sup> macrophages in colorectal cancerJingjing Qi, Hongxiang Sun, Yao Zhang, et al.
Pageof 9

Showing results (71-80 of 82) with videos related to

Sort By:
Pageof 9
European Journal of Medicinal Chemistry|July 3, 2021
Discovery of novel BCR-ABL PROTACs based on the cereblon E3 ligase design, synthesis, and biological evaluationHaixia Liu, Xinyu Ding, Linyi Liu, et al.
Cancer Research|February 25, 2010
Suppression of cyclin D1 by hypoxia-inducible factor-1 via direct mechanism inhibits the proliferation and 5-fluorouracil-induced apoptosis of A549 cellsWen Wen, Jin Ding, Wen Sun, et al.
Journal of Medicinal Chemistry|September 21, 2019
Discovery of SIAIS178 as an Effective BCR-ABL Degrader by Recruiting Von Hippel-Lindau (VHL) E3 Ubiquitin LigaseQuanju Zhao, Chaowei Ren, Linyi Liu, et al.
Scientific Data|May 25, 2024
Head model dataset for mixed reality navigation in neurosurgical interventions for intracranial lesionsZiyu Qi, Haitao Jin, Xinghua Xu, et al.
Communications Biology|November 22, 2025
Genomic and spatial heterogeneity of Brucella melitensis underscores latent brucellosis risks in non-endemic zones in Southwest ChinaFuping Yang, Xiyang Li, Binbin Yu, et al.
Iscience|August 4, 2023
Targeting Bcl-xL is a potential therapeutic strategy for extranodal NK/T cell lymphomaChuanxu Liu, Xinyu Ding, Gaoyang Li, et al.
European Journal of Medicinal Chemistry|October 28, 2022
Discovery and characterization of novel potent BCR-ABL degraders by conjugating allosteric inhibitorHaixia Liu, Qianglong Mi, Xinyu Ding, et al.
Biochemical and Biophysical Research Communications|April 16, 2023
Mechanism of an RBM-targeted rabbit monoclonal antibody 9H1 neutralizing SARS-CoV-2Xiaoyu Chu, Xinyu Ding, Yixuan Yang, et al.
Cell Reports. Medicine|August 26, 2025
An age-related decrease in leptin contributes to CD8<sup>+</sup> T cell aging in the tumor microenvironmentFeixiang Wang, Rujuan Bao, Shuiyu Xu, et al.
Nature Communications|April 2, 2022
Single-cell and spatial analysis reveal interaction of FAP<sup>+</sup> fibroblasts and SPP1<sup>+</sup> macrophages in colorectal cancerJingjing Qi, Hongxiang Sun, Yao Zhang, et al.
Pageof 9